These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20472681)

  • 1. Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.
    de Vries NA; Bruggeman SW; Hulsman D; de Vries HI; Zevenhoven J; Buckle T; Hamans BC; Leenders WP; Beijnen JH; van Lohuizen M; Berns AJ; van Tellingen O
    Clin Cancer Res; 2010 Jul; 16(13):3431-41. PubMed ID: 20472681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.
    Wei Q; Clarke L; Scheidenhelm DK; Qian B; Tong A; Sabha N; Karim Z; Bock NA; Reti R; Swoboda R; Purev E; Lavoie JF; Bajenaru ML; Shannon P; Herlyn D; Kaplan D; Henkelman RM; Gutmann DH; Guha A
    Cancer Res; 2006 Aug; 66(15):7429-37. PubMed ID: 16885338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ink4a/Arf loss promotes tumor recurrence following Ras inhibition.
    Vanbrocklin MW; Robinson JP; Lastwika KJ; McKinney AJ; Gach HM; Holmen SL
    Neuro Oncol; 2012 Jan; 14(1):34-42. PubMed ID: 22015595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
    Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
    Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.
    Ghazi SO; Stark M; Zhao Z; Mobley BC; Munden A; Hover L; Abel TW
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):729-40. PubMed ID: 22805776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral-induced high-grade gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H.
    Lynes J; Wibowo M; Koschmann C; Baker GJ; Saxena V; Muhammad AK; Bondale N; Klein J; Assi H; Lieberman AP; Castro MG; Lowenstein PR
    Neurotherapeutics; 2014 Jul; 11(3):623-35. PubMed ID: 24752661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro.
    Chintala SK; Fueyo J; Gomez-Manzano C; Venkaiah B; Bjerkvig R; Yung WK; Sawaya R; Kyritsis AP; Rao JS
    Oncogene; 1997 Oct; 15(17):2049-57. PubMed ID: 9366522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma.
    Smilowitz HM; Weissenberger J; Weis J; Brown JD; O'Neill RJ; Laissue JA
    J Neurosurg; 2007 Apr; 106(4):652-9. PubMed ID: 17432718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational research strategies applied to glioma therapeutics.
    Berger MS; Keles GE
    Clin Neurosurg; 2004; 51():203-6. PubMed ID: 15571146
    [No Abstract]   [Full Text] [Related]  

  • 13. SCCRO promotes glioma formation and malignant progression in mice.
    Broderick SR; Golas BJ; Pham D; Towe CW; Talbot SG; Kaufman A; Bains S; Huryn LA; Yonekawa Y; Carlson D; Hambardzumyan D; Ramanathan Y; Singh B
    Neoplasia; 2010 Jun; 12(6):476-84. PubMed ID: 20563250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of new transgenic mouse models in glioma research.
    Sonabend AM; Ulasov IV; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
    Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
    Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo.
    Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI
    Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine cell line model of proneural glioma for evaluation of anti-tumor therapies.
    Sonabend AM; Yun J; Lei L; Leung R; Soderquist C; Crisman C; Gill BJ; Carminucci A; Sisti J; Castelli M; Sims PA; Bruce JN; Canoll P
    J Neurooncol; 2013 May; 112(3):375-82. PubMed ID: 23504257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
    Muñoz DM; Tung T; Agnihotri S; Singh S; Guha A; Zadeh G; Hawkins C
    Glia; 2013 Nov; 61(11):1862-72. PubMed ID: 24038521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
    McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
    Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.